Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Tianjin Third Central Hospital

Clinical trials sponsored by Tianjin Third Central Hospital, explained in plain language.

Not yet recruiting 1
Sort by
  • New ultrasound contrast agent could spot liver cancer sooner

    Diagnosis Not yet recruiting

    This study will test whether using a contrast agent called Sonazoid during ultrasound can find early-stage liver cancer better than standard ultrasound alone. About 556 adults with liver cirrhosis will be scanned every 4 to 6 months. The goal is to see if this method catches more…

    Phase: NA • Sponsor: Tianjin Third Central Hospital • Aim: Diagnosis

    Last updated Jun 27, 2026 12:33 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space